tiprankstipranks
AstraZeneca PLC (AZN)
NYSE:AZN
US Market
AZN
AstraZeneca
RESEARCH TOOLSreports

AstraZeneca (AZN) Income Statement

367 Followers

AstraZeneca Income Statement

Last quarter (Q4 2025), AstraZeneca's total revenue was $15.50B, an increase of 6.64% from the same quarter last year. In Q4, AstraZeneca's net income was $2.33B. See AstraZeneca’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 58.74B$ 52.94B$ 46.58B$ 44.25B$ 37.11B
Gross Profit
$ 48.11B$ 39.70B$ 34.45B$ 28.04B$ 22.60B
Operating Expenses
$ 34.36B$ 27.18B$ 24.88B$ 22.99B$ 19.79B
Depreciation and Amortization
$ 5.73B$ 4.96B$ 5.02B$ 5.24B$ 4.02B
EBITDA
$ 19.83B$ 14.86B$ 13.20B$ 8.63B$ 4.59B
Operating Income
$ 13.74B$ 12.52B$ 9.57B$ 5.05B$ 2.81B
Other Income/Expenses
$ -1.34B$ -4.01B$ -2.55B$ -2.55B$ -3.07B
Pretax Income
$ 12.40B$ 8.51B$ 7.02B$ 2.50B$ -259.92M
Net Income
$ 10.22B$ 6.89B$ 6.06B$ 3.28B$ 109.85M
Per Share Metrics
Basic EPS
$ 6.60$ 4.44$ 3.91$ 2.12$ 0.08
Diluted EPS
$ 6.54$ 4.41$ 3.88$ 2.10$ 0.08
Weighted Average Shares Outstanding
 1.55B 1.55B 1.56B 1.55B 1.42B
Weighted Average Shares Outstanding (Diluted)
 1.56B 1.56B 1.56B 1.56B 1.43B
Currency in USD

AstraZeneca Earnings and Revenue History